The University of Maryland is home to a high-volume liver transplant program, changing the lives of more than 80 patients a year with the most advanced cases liver failure.
The team of liver transplant surgeons works closely with physicians within the University of Maryland Liver Center, a multidisciplinary practice comprised of hepatologists, pathologists, interventional radiologists, medical and surgical oncologists, general surgeons and nursing staff who all specialize in the medical and surgical management of liver, gall bladder and bile duct disease.
The transplant team has an approved protocol for the treatment of hilar cholangiocarcinoma, a rare yet lethal form of bile duct cancer, which involves a combination of medical and interventional radiologic therapies prior to receiving a liver transplant. Only a handful of transplant programs in the country offer this treatment for hilar cholangiocarcinoma.
Learn from these stories of patients who have received liver transplants at the University of Maryland Medical Center.
This page was last updated: December 4, 2013